| 中文名 | 2-(4-羟基苯基)-1-(1,3,4,9-四氢-2H-吡啶并[3,4-B]吲哚-2-基)乙烷-1-酮 |
|---|---|
| 英文名 | YH-306 |
| 英文别名 |
YH-306, 10 mM in DMSO
YH-306/1373-0 1-(3,4-Dihydro-1H-pyrido[3,4-b]indol-2(9H)-yl)-2-(4-hydroxyphenyl)ethanone 2-(4-Hydroxyphenyl)-1-(1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)ethan-1-one , YH-306 2-(4-Hydroxyphenyl)-1-(1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)ethan-1-one 2-(4-Hydroxyphenyl)-1-(1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-ethanone Ethanone, 2-(4-hydroxyphenyl)-1-(1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl) 2-(4-hydroxyphenyl)-1-{1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl}ethan-1-one YH306 T24642 |
| 描述 | YH-306是通过调节FAK信号通路来预防结直肠癌生长和转移的候选药物。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C19H18N2O2 |
|---|---|
| 分子量 | 306.36 |